Cell-based therapy for degenerative retinal disease

Trends in Molecular Medicine

Volumn 22, Issue 2, 2016, Pages 115-134

  Zarbin, Marco ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLATE MOFETIL; PREDNISONE; TACROLIMUS;

AGE RELATED MACULAR DEGENERATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL SURVIVAL; CLINICAL FEATURE; GEOGRAPHIC ATROPHY; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; MACULAR DEGENERATION; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHOTORECEPTOR; PIGMENT EPITHELIUM; RETINA CELL; RETINA DEGENERATION; RETINITIS PIGMENTOSA; REVIEW; STEM CELL TRANSPLANTATION; SYNAPSE; VISION; ANIMAL; BIOLOGICAL THERAPY; CLINICAL TRIAL (TOPIC); CYTOLOGY; DISEASE MODEL; EMBRYONIC STEM CELL; INDUCED PLURIPOTENT STEM CELL; MOUSE; PATHOLOGY; PHYSIOLOGY; PROCEDURES; RAT; RETINAL PIGMENT EPITHELIUM; TISSUE ENGINEERING; TRANSPLANTATION; VERTEBRATE PHOTORECEPTOR CELL;

ANIMALS; CELL DIFFERENTIATION; CELL- AND TISSUE-BASED THERAPY; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MACULAR DEGENERATION; MICE; PHOTORECEPTOR CELLS, VERTEBRATE; RATS; RETINAL PIGMENT EPITHELIUM; RETINITIS PIGMENTOSA; TISSUE ENGINEERING;

EID: 84960369637     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2015.12.007     Document Type: Review

References (158)

1. Parmeggiani F. Clinics, epidemiology and genetics of retinitis pigmentosa. Curr. Genomics 2011, 12:236-237.
2. Wong, W.L. et al. (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040, a systematic review and meta-analysis. Lancet Glob Health 2, e106-116.
3. Genead M.A., et al. The natural history of Stargardt disease with specific sequence mutation in the ABCA4 gene. Invest. Ophthalmol. Vis. Sci. 2009, 50:5867-5871.
4. Ashtari M., et al. Plasticity of the human visual system after retinal gene therapy in patients with Leber's congenital amaurosis. Sci. Transl. Med. 2015, 7:296ra110.
5. Jacobson S.G., et al. Improvement and decline in vision with gene therapy in childhood blindness. N. Engl. J. Med. 2015, 372:1920-1926.
6. Zarbin M.A., Rosenfeld P.J. Pathway-based therapies for age-related macular degeneration: an integrated survey of emerging treatment alternatives. Retina 2010, 30:1350-1367.
7. Rosenfeld P.J., et al. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 2006, 355:1419-1431.
8. Brown D.M., et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N. Engl. J. Med. 2006, 355:1432-1444.
9. Heier J.S., et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 2012, 119:2537-2548.
10. Zarbin M.A., Rosenfeld P.J. Review of emerging treatments of age-related macular degeneration. Oxidative Stress in Applied Basic Research and Clinical Practice: Studies in Retinal and Choroidal Disorders 2012, 1-46. Humana Press. R.D. Stratton (Ed.).
11. Schwartz S.D., et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 2012, 379:713-720.
12. Schwartz S.D., et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet 2015, 385:509-516.
13. Song W.K., et al. Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in asian patients. Stem Cell Rep. 2015, 4:860-872.
14. Sung C.H., Chuang J.Z. The cell biology of vision. J. Cell Biol. 2010, 190:953-963.
15. Ramsden C.M., et al. Dev. Ophthalmol. 2014, 53:97-110.
16. Binder S., et al. Transplantation of the RPE in AMD. Prog. Retin. Eye Res. 2007, 26:516-554.
17. Streilein J.W. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J. Leukoc. Biol. 2003, 74:179-185.
18. Zarbin M.A., et al. Age-related macular degeneration: clinical findings, histopathology, imaging techniques. Cell-Based Therapy for Retinal Degenerative Disease 2014, Karger Medical and Scientific Publishers, (in press). R.P. Casaroli-Marano, M.A. Zarbin (Eds.).
19. Menghini M., Duncan J.L. Diagnosis and complementary examinations. Dev. Ophthalmol. 2014, 53:53-69.
20. Scoles D., et al. Assessing photoreceptor structure associated with ellipsoid zone disruptions visualized with optical coherence tomography. Retina 2015, 36:91-103.
21. Zayit-Soudry S., et al. Cone structure imaged with adaptive optics scanning laser ophthalmoscopy in eyes with nonneovascular age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2013, 54:7498-7509.
22. Pearson R.A., et al. Restoration of vision after transplantation of photoreceptors. Nature 2012, 485:99-103.
23. Zhong X., et al. Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs. Nat. Commun. 2014, 5:4047.
24. Phillips M.J., et al. Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses. Invest. Ophthalmol. Vis. Sci. 2012, 53:2007-2019.
25. Klimanskaya I., et al. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 2004, 6:217-245.
26. Osakada F., et al. Stepwise differentiation of pluripotent stem cells into retinal cells. Nat. Protoc. 2009, 4:811-824.
27. Reichman S., et al. From confluent human iPS cells to self-forming neural retina and retinal pigmented epithelium. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:8518-8523.
28. Lamba D.A., et al. Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells. PLoS ONE 2010, 5:e8763.
29. Ohlemacher S.K., et al. Generation of highly enriched populations of optic vesicle-like retinal cells from human pluripotent stem cells. Curr. Protoc. Stem Cell Biol. 2015, 32:1H8.
30. Tucker B.A., et al. Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation. Stem Cells Transl. Med. 2013, 2:16-24.
31. Karl M.O., Reh T.A. Regenerative medicine for retinal diseases: activating endogenous repair mechanisms. Trends Mol. Med. 2010, 16:193-202.
32. Pollak J., et al. ASCL1 reprograms mouse Muller glia into neurogenic retinal progenitors. Development 2013, 140:2619-2631.
33. Del Debbio C.B., et al. Notch and Wnt signaling mediated rod photoreceptor regeneration by Muller cells in adult mammalian retina. PLoS ONE 2010, 5:e12425.
34. Bernardos R.L., et al. Late-stage neuronal progenitors in the retina are radial Muller glia that function as retinal stem cells. J. Neurosci. 2007, 27:7028-7040.
35. Jayaram H., et al. Transplantation of photoreceptors derived from human Muller glia restore rod function in the P23H rat. Stem Cells Transl. Med. 2014, 3:323-333.
36. Ahmad I., et al. Neural stem cells in the mammalian eye: types and regulation. Semin. Cell Dev. Biol. 2004, 15:53-62.
37. Tropepe V., et al. Retinal stem cells in the adult mammalian eye. Science 2000, 287:2032-2036.
38. Salero E., et al. Adult human RPE can be activated into a multipotent stem cell that produces mesenchymal derivatives. Cell Stem Cell 2012, 10:88-95.
39. Blenkinsop T.A., et al. The culture and maintenance of functional retinal pigment epithelial monolayers from adult human eye. Methods Mol. Biol. 2013, 945:45-65.
40. Jones B.W., et al. Retinal remodeling triggered by photoreceptor degenerations. J. Comp. Neurol. 2003, 464:1-16.
41. Cuenca N., et al. Regressive and reactive changes in the connectivity patterns of rod and cone pathways of P23H transgenic rat retina. Neuroscience 2004, 127:301-317.
42. Khodair M.A., et al. Synaptic plasticity in mammalian photoreceptors prepared as sheets for retinal transplantation. Invest. Ophthalmol. Vis. Sci. 2003, 44:4976-4988.
43. Lewis G.P., et al. Neurite outgrowth from bipolar and horizontal cells after experimental retinal detachment. Invest. Ophthalmol. Vis. Sci. 1998, 39:424-434.
44. Akimoto M., et al. Targeting of GFP to newborn rods by Nrl promoter and temporal expression profiling of flow-sorted photoreceptors. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:3890-3895.
45. MacLaren R.E., et al. Retinal repair by transplantation of photoreceptor precursors. Nature 2006, 444:203-207.
46. Pearson R.A. Advances in repairing the degenerate retina by rod photoreceptor transplantation. Biotechnol. Adv. 2014, 32:485-491.
47. Singh M.S., et al. Reversal of end-stage retinal degeneration and restoration of visual function by photoreceptor transplantation. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:1101-1106.
48. Noell W.K. The impairment of visual cell structure by iodoacetate. J. Cell. Physiol. 1952, 40:25-55.
49. Wang W., et al. Swine cone and rod precursors arise sequentially and display sequential and transient integration and differentiation potential following transplantation. Invest. Ophthalmol. Vis. Sci. 2014, 55:301-309.
50. Gonzalez-Cordero A., et al. Photoreceptor precursors derived from three-dimensional embryonic stem cell cultures integrate and mature within adult degenerate retina. Nat. Biotechnol. 2013, 31:741-747.
51. Eiraku M., et al. Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature 2011, 472:51-56.
52. Barber A.C., et al. Repair of the degenerate retina by photoreceptor transplantation. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:354-359.
53. Pearson R.A., et al. Targeted disruption of outer limiting membrane junctional proteins (Crb1 and ZO-1) increases integration of transplanted photoreceptor precursors into the adult wild-type and degenerating retina. Cell Transplant. 2010, 19:487-503.
54. West E.L., et al. Pharmacological disruption of the outer limiting membrane leads to increased retinal integration of transplanted photoreceptor precursors. Exp. Eye Res. 2008, 86:601-611.
55. Yang Y., et al. Functional cone rescue by RdCVF protein in a dominant model of retinitis pigmentosa. Mol. Ther. 2009, 17:787-795.
56. Yang Y., et al. Transplantation of photoreceptor and total neural retina preserves cone function in P23H rhodopsin transgenic rat. PLoS ONE 2010, 5:e13469.
57. Santos-Ferreira T., et al. Daylight vision repair by cell transplantation. Stem Cells 2015, 33:79-90.
58. Mears A.J., et al. Nrl is required for rod photoreceptor development. Nat. Genet. 2001, 29:447-452.
59. Chang B., et al. A homologous genetic basis of the murine cpfl1 mutant and human achromatopsia linked to mutations in the PDE6C gene. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:19581-19586.
60. Lakowski J., et al. Cone and rod photoreceptor transplantation in models of the childhood retinopathy Leber congenital amaurosis using flow-sorted Crx-positive donor cells. Hum. Mol. Genet. 2010, 19:4545-4559.
61. Freund C.L., et al. Cone-rod dystrophy due to mutations in a novel photoreceptor-specific homeobox gene (CRX) essential for maintenance of the photoreceptor. Cell 1997, 91:543-553.
62. -/- mouse model of leber congenital amaurosis-1. Hum. Gene Ther. 2015, 26:575-592.
63. Geller A.M., Sieving P.A. How many cones are required to 'see?': lessons from Stargardt's macular dystrophy and from modeling with degenerate photoreceptor arrays. Retinal Degeneration. Clinical And Laboratory Applications 1993, 25-34. Plenum Press. J.G. Hollyfield (Ed.).
64. Wang Q., et al. Adaptive optics microperimetry and OCT images show preserved function and recovery of cone visibility in macular telangiectasia type 2 retinal lesions. Invest. Ophthalmol. Vis. Sci. 2015, 56:778-786.
65. Sakai T., et al. Cone photoreceptor recovery after experimental detachment and reattachment: an immunocytochemical, morphological, and electrophysiological study. Invest. Ophthalmol. Vis. Sci. 2003, 44:416-425.
66. Lawrence J.M., et al. Transplantation of Schwann cell line clones secreting GDNF or BDNF into the retinas of dystrophic Royal College of Surgeons Rats. Invest. Ophthalmol. Vis. Sci. 2004, 45:267-274.
67. Kolomeyer A.M., Zarbin M.A. Trophic factors in the pathogenesis and therapy for retinal degenerative diseases. Surv. Ophthalmol. 2014, 59:134-165.
68. Lund R.D., et al. Subretinal transplantation of genetically modified human cell lines attenuates loss of visual function in dystrophic rats. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:9942-9947.
69. Charbel Issa P., et al. Characterisation of severe rod-cone dystrophy in a consanguineous family with a splice site mutation in the MERTK gene. Br. J. Ophthalmol. 2009, 93:920-925.
70. Mackay D.S., et al. Novel mutations in MERTK associated with childhood onset rod-cone dystrophy. Mol. Vis. 2010, 16:369-377.
71. Vollrath D., et al. Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:12584-12589.
72. Gullapalli V.K., et al. Transplantation Frontiers. Retina 2013, 2058-2077. Elsevier. 5th Edn. S.J. Ryan (Ed.).
73. Carr A.J., et al. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS ONE 2009, 4:e8152.
74. Wang S., et al. Long-term vision rescue by human neural progenitors in a rat model of photoreceptor degeneration. Invest. Ophthalmol. Vis. Sci. 2008, 49:3201-3206.
75. Lu B., et al. Cell transplantation to arrest early changes in an ush2a animal model. Invest. Ophthalmol. Vis. Sci. 2010, 51:2269-2276.
76. Sareen D., et al. Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord. J. Comp. Neurol. 2014, 522:2707-2728.
77. Tsai Y., et al. Human iPSC-derived neural progenitors preserve vision in an AMD-like model. Stem Cells 2015, 33:2537-2549.
78. Cuenca N., et al. Phagocytosis of photoreceptor outer segments by transplanted human neural stem cells as a neuroprotective mechanism in retinal degeneration. Invest. Ophthalmol. Vis. Sci. 2013, 54:6745-6756.
79. McGill T.J., et al. Transplantation of human central nervous system stem cells - neuroprotection in retinal degeneration. Eur. J. Neurosci. 2012, 35:468-477.
80. Jacobson S.G., et al. Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch. Ophthalmol. 2012, 130:9-24.
81. Shen Y., et al. X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:4709-4714.
82. Panning B., et al. X chromosome inactivation is mediated by Xist RNA stabilization. Cell 1997, 90:907-916.
83. Anguera M.C., et al. Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes. Cell Stem Cell 2012, 11:75-90.
84. Kokkinaki M., et al. Human induced pluripotent stem-derived retinal pigment epithelium (RPE) cells exhibit ion transport, membrane potential, polarized vascular endothelial growth factor secretion, and gene expression pattern similar to native RPE. Stem Cells 2011, 29:825-835.
85. Feng Q., et al. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 2010, 28:704-712.
86. Sheu J., et al. Cellular manufacturing for clinical applications. Dev. Ophthalmol. 2014, 53:178-188.
87. Bharti K., et al. Developing cellular therapies for retinal degenerative diseases. Invest. Ophthalmol. Vis. Sci. 2014, 55:1191-1202.
88. Nazari H., et al. Stem cell based therapies for age-related macular degeneration: The promises and the challenges. Prog. Retin. Eye Res. 2015, 48:1-39.
89. Whiting P., et al. Progressing a human embryonic stem-cell-based regenerative medicine therapy towards the clinic. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2015, 370:20140375.
90. Kamao H., et al. Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Rep. 2014, 2:205-218.
91. Croze R.H., Clegg D.O. Differentiation of pluripotent stem cells into retinal pigmented epithelium. Dev. Ophthalmol. 2014, 53:81-96.
92. Buchholz D.E., et al. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells 2009, 27:2427-2434.
93. Zhou S., et al. Differentiation of human embryonic stem cells into cone photoreceptors through simultaneous inhibition of BMP, TGFbeta and Wnt signaling. Development 2015, 142:3294-3306.
94. + cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings. Invest. Ophthalmol. Vis. Sci. 2015, 56:81-89.
95. Otani A., et al. Rescue of retinal degeneration by intravitreally injected adult bone marrow-derived lineage-negative hematopoietic stem cells. J. Clin. Invest. 2004, 114:765-774.
96. Li Y., et al. Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa. Mol. Med. 2012, 18:1312-1319.
97. Stanzel B.V., et al. Human RPE stem cells grown into polarized RPE monolayers on a polyester matrix are maintained after grafting into rabbit subretinal space. Stem Cell Rep. 2014, 2:64-77.
98. Diniz B., et al. Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer. Invest. Ophthalmol. Vis. Sci. 2013, 54:5087-5096.
99. Hsiung J., et al. Polarized human embryonic stem cell-derived retinal pigment epithelial cell monolayers have higher resistance to oxidative stress-induced cell death than nonpolarized cultures. Stem Cells Transl. Med. 2015, 4:10-20.
100. Zhang X., Bok D. Transplantation of retinal pigment epithelial cells and immune response in the subretinal space. Invest. Ophthalmol. Vis. Sci. 1998, 39:1021-1027.
101. Redenti S., et al. Retinal tissue engineering using mouse retinal progenitor cells and a novel biodegradable, thin-film poly(e-caprolactone) nanowire scaffold. J. Ocul. Biol. Dis. Infor. 2008, 1:19-29.
102. Tao S., et al. Survival, migration and differentiation of retinal progenitor cells transplanted on micro-machined poly(methyl methacrylate) scaffolds to the subretinal space. Lab Chip 2007, 7:695-701.
103. Tucker B.A., et al. The use of progenitor cell/biodegradable MMP2-PLGA polymer constructs to enhance cellular integration and retinal repopulation. Biomaterials 2010, 31:9-19.
104. MacLaren R.E., et al. Autologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration. Ophthalmology 2007, 114:561-570.
105. Tezel T.H., et al. Adult retinal pigment epithelial transplantation in exudative age-related macular degeneration. Am. J. Ophthalmol. 2007, 143:584-595.
106. Falkner-Radler C.I., et al. Human retinal pigment epithelium (RPE) transplantation: outcome after autologous RPE-choroid sheet and RPE cell-suspension in a randomised clinical study. Br. J. Ophthalmol. 2011, 95:370-375.
107. Kundu J., et al. Approaches to cell delivery: substrates and scaffolds for cell therapy. Dev. Ophthalmol. 2014, 53:143-154.
108. Carr A.J., et al. Development of human embryonic stem cell therapies for age-related macular degeneration. Trends Neurosci. 2013, 36:385-395.
109. Lu B., et al. Microdevice-based cell therapy for age-related macular degeneration. Dev. Ophthalmol. 2014, 53:155-166.
110. Lu B., et al. Mesh-supported submicron parylene-C membranes for culturing retinal pigment epithelial cells. Biomed. Microdevices 2012, 14:659-667.
111. Seiler M.J., et al. Visual restoration and transplant connectivity in degenerate rats implanted with retinal progenitor sheets. Eur. J. Neurosci. 2010, 31:508-520.
112. Assawachananont J., et al. Transplantation of embryonic and induced pluripotent stem cell-derived 3D retinal sheets into retinal degenerative mice. Stem Cell Rep. 2014, 2:662-674.
113. Radtke N.D., et al. Vision improvement in retinal degeneration patients by implantation of retina together with retinal pigment epithelium. Am. J. Ophthalmol. 2008, 146:172-182.
114. Radtke N.D., et al. Preliminary report: indications of improved visual function after retinal sheet transplantation in retinitis pigmentosa patients. Am. J. Ophthalmol. 1999, 128:384-387.
115. Huang J.C., et al. Preparation and transplantation of photoreceptor sheets. Curr. Eye Res. 1998, 17:573-585.
116. Sunness J.S. Stem cells in age-related macular degeneration and Stargardt's macular dystrophy. Lancet 2015, 386:29.
117. Zarbin M.A. Current concepts in the pathogenesis of age-related macular degeneration. Arch. Ophthalmol. 2004, 122:598-614.
118. Sugino I.K., et al. Comparison of FRPE and human embryonic stem cell-derived RPE behavior on aged human Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 2011, 52:4979-4997.
119. Sugino I.K., et al. A method to enhance cell survival on Bruch's membrane in eyes affected by age and age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2011, 52:9598-9609.
120. Hu J., Bok D. A cell culture medium that supports the differentiation of human retinal pigment epithelium into functionally polarized monolayers. Mol. Vis. 2001, 7:14-19.
121. Bharti K., et al. The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells. Pigment Cell Melanoma Res. 2011, 24:21-34.
122. Khodair M.A., et al. Cyclic AMP prevents retraction of axon terminals in photoreceptors prepared for transplantation: an in vitro study. Invest. Ophthalmol. Vis. Sci. 2005, 46:967-973.
123. Fontainhas A.M., Townes-Anderson E. RhoA inactivation prevents photoreceptor axon retraction in an in vitro model of acute retinal detachment. Invest. Ophthalmol. Vis. Sci. 2011, 52:579-587.
124. Suzuki T., et al. Chondroitinase ABC treatment enhances synaptogenesis between transplant and host neurons in model of retinal degeneration. Cell Transplant. 2007, 16:493-503.
125. Wenkel H., Streilein J.W. Evidence that retinal pigment epithelium functions as an immune- privileged tissue. Invest. Ophthalmol. Vis. Sci. 2000, 41:3467-3473.
126. Zamiri P., et al. Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation. Invest. Ophthalmol. Vis. Sci. 2006, 47:3912-3918.
127. Zamiri P., et al. Immunosuppressive properties of the pigmented epithelial cells and the subretinal space. Chem. Immunol. Allergy 2007, 92:86-93.
128. Wenkel H., Streilein J.W. Analysis of immune deviation elicited by antigens injected into the subretinal space. Invest. Ophthalmol. Vis. Sci. 1998, 39:1823-1834.
129. Zamiri P., et al. Vulnerability of allogeneic retinal pigment epithelium to immune T-cell-mediated damage in vivo and in vitro. Invest. Ophthalmol. Vis. Sci. 2004, 45:177-184.
130. Enzmann V., et al. Down-regulation of MHC class II expression on bovine retinal pigment epithelial cells by cytokines. Ophthalmic Res. 1999, 31:256-266.
131. West E.L., et al. Long-term survival of photoreceptors transplanted into the adult murine neural retina requires immune modulation. Stem Cells 2010, 28:1997-2007.
132. Fairchild P.J. The challenge of immunogenicity in the quest for induced pluripotency. Nat. Rev. Immunol. 2010, 10:868-875.
133. Zhao T., et al. Immunogenicity of induced pluripotent stem cells. Nature 2011, 474:212-215.
134. Robertson N.J., et al. Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:20920-20925.
135. Boyd A.S., Fairchild P.J. Approaches for immunological tolerance induction to stem cell-derived cell replacement therapies. Expert Rev. Clin. Immunol. 2010, 6:435-448.
136. Nakatsuji N., et al. HLA-haplotype banking and iPS cells. Nat. Biotechnol. 2008, 26:739-740.
137. Zimmermann A., et al. Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations. Stem Cells Dev. 2012, 21:2364-2373.
138. Taylor C.J., et al. Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types. Cell Stem Cell 2012, 11:147-152.
139. Turner M., et al. Toward the development of a global induced pluripotent stem cell library. Cell Stem Cell 2012, 13:382-384.
140. Tena A., Sachs D.H. Stem cells: immunology and immunomodulation. Dev. Ophthalmol. 2014, 53:122-132.
141. Vincenti F., et al. Five-year safety and efficacy of belatacept in renal transplantation. J. Am. Soc. Nephrol. 2010, 21:1587-1596.
142. Webber A., et al. Novel strategies in immunosuppression: issues in perspective. Transplantation 2011, 91:1057-1064.
143. Kaplan H.J., et al. Fas ligand (CD95 ligand) controls angiogenesis beneath the retina. Nat. Med. 1999, 5:292-297.
144. Arnhold S., et al. Neurally selected embryonic stem cells induce tumor formation after long-term survival following engraftment into the subretinal space. Invest. Ophthalmol. Vis. Sci. 1999, 45:4251-4255.
145. Nakagawa M., et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 1999, 26:101-106.
146. Li W., et al. Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 2009, 27:2992-3000.
147. Zhu S., et al. Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 2010, 7:651-655.
148. Huangfu D., et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol. 2008, 26:1269-1275.
149. Shi Y., et al. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 2008, 3:568-574.
150. Okita K., et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008, 322:949-953.
151. Yu J., et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009, 324:797-801.
152. Kaji K., et al. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009, 458:771-775.
153. Warren L., et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010, 7:618-630.
154. Zhou H., et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009, 4:381-384.
155. Kim D., et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009, 4:472-476.
156. Balasubramanian S., et al. Non cell-autonomous reprogramming of adult ocular progenitors: generation of pluripotent stem cells without exogenous transcription factors. Stem Cells 2009, 27:3053-3062.
157. Muller F.J., et al. A bioinformatic assay for pluripotency in human cells. Nat. Methods 2011, 8:315-317.
158. Coughlan A. Mutation alert halts stem-cell trial to cure blindness. New Sci. 2015, 31 July, https://www.newscientist.com/article/dn27986/.